Cipla Limited
CIPLADrug Manufacturers - Specialty & Generic
₹1,378.90+1.54%As of Oct 30vs prior close
- Market cap
- $11.7B
- P/E (TTM)
- 38.5×
- P/E (FY1)
- 27.2×
- From 52W high
- −9.63%
- EPS (LTM)
- ₹41.70
- Revenue (LTM)
- ₹280.7B
- Net margin
- 10.35%
- Dividend yield
- 0.94%
Nomior Score
52
Steady ProfileTop 46% of the scored universe
Growth64
Quality50
Value51
Momentum25
Resilience69
Growth
+7.23%revenue a year over 3 fiscal years
YE23 ₹224.7BLTM ₹280.7B
Connections
Revenue to profitYE26
14% of revenue became net profit, down 5 pts on a year.